Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

The Potential Impact of Scribes on Medical School Applicants and Medical Students with the New Clinical Documentation Guidelines.

DeWitt D, Harrison LE.

J Gen Intern Med. 2018 Jul 31. doi: 10.1007/s11606-018-4582-8. [Epub ahead of print]

PMID:
30066114
2.

Spindle Assembly Disruption and Cancer Cell Apoptosis with a CLTC-Binding Compound.

Bond MJ, Bleiler M, Harrison LE, Scocchera EW, Nakanishi M, G-Dayanan N, Keshipeddy S, Rosenberg DW, Wright DL, Giardina C.

Mol Cancer Res. 2018 Sep;16(9):1361-1372. doi: 10.1158/1541-7786.MCR-18-0178. Epub 2018 May 16.

PMID:
29769406
3.

Development of a brief assessment of activity limitations in children with food allergy.

Peterson CC, Harrison LE.

Ann Allergy Asthma Immunol. 2018 Mar;120(3):327-328. doi: 10.1016/j.anai.2017.10.032. Epub 2017 Dec 6. No abstract available.

PMID:
29203234
4.

A look into centrosome abnormalities in colon cancer cells, how they arise and how they might be targeted therapeutically.

Harrison LE, Bleiler M, Giardina C.

Biochem Pharmacol. 2018 Jan;147:1-8. doi: 10.1016/j.bcp.2017.11.003. Epub 2017 Nov 9. Review.

PMID:
29128368
5.

What's good for the goose is not always good for the gander-are conclusions from a clinical trial always universally exportable?

Harrison LE.

Transl Gastroenterol Hepatol. 2016 Apr 13;1:33. doi: 10.21037/tgh.2016.03.26. eCollection 2016. No abstract available.

6.

Patients with chronic kidney disease have abnormal upper gastro-intestinal tract digestive function: A study of uremic enteropathy.

Grant CJ, Harrison LE, Hoad CL, Marciani L, Gowland PA, McIntyre CW.

J Gastroenterol Hepatol. 2017 Feb;32(2):372-377. doi: 10.1111/jgh.13458.

PMID:
27222079
7.

Robotic gastrectomy and esophagogastrectomy: A single center experience of 105 cases.

Harrison LE, Yiengpruksawan A, Patel J, Itskovich A, Lee B, Korst R.

J Surg Oncol. 2015 Dec;112(8):888-93. doi: 10.1002/jso.24073. Epub 2015 Oct 21.

PMID:
26487124
8.

Circulating endotoxaemia and frequent haemodialysis schedules.

Jefferies HJ, Crowley LE, Harrison LE, Szeto CC, Li PK, Schiller B, Moran J, McIntyre CW.

Nephron Clin Pract. 2014;128(1-2):141-6. doi: 10.1159/000366519. Epub 2014 Nov 12.

PMID:
25401768
9.

Central venous oxygen saturation: a potential new marker for circulatory stress in haemodialysis patients?

Harrison LE, Selby NM, McIntyre CW.

Nephron Clin Pract. 2014;128(1-2):57-60. doi: 10.1159/000362557. Epub 2014 Oct 23.

PMID:
25342499
10.

Comparing Canadian and American normative scores on the Wechsler Adult Intelligence Scale-Fourth Edition.

Harrison AG, Armstrong IT, Harrison LE, Lange RT, Iverson GL.

Arch Clin Neuropsychol. 2014 Dec;29(8):737-46. doi: 10.1093/arclin/acu048. Epub 2014 Oct 13.

PMID:
25313225
11.

A phase I trial of thermal sensitization using induced oxidative stress in the context of HIPEC.

Harrison LE, Tiesi G, Razavi R, Wang CC.

Ann Surg Oncol. 2013 Jun;20(6):1843-50. doi: 10.1245/s10434-013-2874-0. Epub 2013 Jan 26.

PMID:
23354567
12.

Endotoxaemia in haemodialysis: a novel factor in erythropoetin resistance?

Harrison LE, Burton JO, Szeto CC, Li PK, McIntyre CW.

PLoS One. 2012;7(6):e40209. doi: 10.1371/journal.pone.0040209. Epub 2012 Jun 29.

13.

The impact of antihypertensive drug therapy on endotoxemia in elderly patients with chronic kidney disease.

John SG, Owen PJ, Harrison LE, Szeto CC, Lai KB, Li PK, McIntyre CW.

Clin J Am Soc Nephrol. 2011 Oct;6(10):2389-94. doi: 10.2215/CJN.11211210. Epub 2011 Aug 18.

14.

Periaortic pancreatic rests: a case report.

Heller DS, Harrison LE, Peters S.

J Reprod Med. 2010 Sep-Oct;55(9-10):430-2.

PMID:
21043370
15.

Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease.

McIntyre CW, Harrison LE, Eldehni MT, Jefferies HJ, Szeto CC, John SG, Sigrist MK, Burton JO, Hothi D, Korsheed S, Owen PJ, Lai KB, Li PK.

Clin J Am Soc Nephrol. 2011 Jan;6(1):133-41. doi: 10.2215/CJN.04610510. Epub 2010 Sep 28.

16.

Simultaneous bicavitary hyperthermic chemoperfusion in the management of pseudomyxoma peritonei with synchronous pleural extension.

Senthil M, Harrison LE.

Arch Surg. 2009 Oct;144(10):970-2. doi: 10.1001/archsurg.2009.166.

PMID:
19841367
17.

Thermal sensitization using induced oxidative stress decreases tumor growth in an in vivo model of hyperthermic intraperitoneal perfusion.

Razavi R, Harrison LE.

Ann Surg Oncol. 2010 Jan;17(1):304-11. doi: 10.1245/s10434-009-0674-3. Epub 2009 Aug 27.

PMID:
19711132
18.

Epigenetic alteration of p16INK4a gene in dedifferentiation of liposarcoma.

He M, Aisner S, Benevenia J, Patterson F, Harrison LE, Hameed M.

Pathol Res Pract. 2009;205(6):386-94. doi: 10.1016/j.prp.2008.12.009. Epub 2009 Jan 30.

PMID:
19186005
19.

Hyperthermia in combination with oxidative stress induces autophagic cell death in HT-29 colon cancer cells.

Chen F, Wang CC, Kim E, Harrison LE.

Cell Biol Int. 2008 Jul;32(7):715-23. doi: 10.1016/j.cellbi.2008.02.010. Epub 2008 Mar 4.

PMID:
18396422
20.

Proteasome inhibition potentiates the cytotoxic effects of hyperthermia in HT-29 colon cancer cells through inhibition of heat shock protein 27.

Chen F, Rezavi R, Wang CC, Harrison LE.

Oncology. 2007;73(1-2):98-103. doi: 10.1159/000120997. Epub 2008 Mar 13.

PMID:
18337621
21.
22.
23.

CDK5 is a novel regulatory protein in PPARgamma ligand-induced antiproliferation.

Kim E, Chen F, Wang CC, Harrison LE.

Int J Oncol. 2006 Jan;28(1):191-4.

PMID:
16327995
24.
25.

Selecting the highly selective.

Harrison LE.

Ann Surg Oncol. 2005 Jun;12(6):420-1. Epub 2005 Apr 27. No abstract available.

PMID:
15886902
26.

Hepatitis status, child-pugh classification, and serum AFP levels predict survival in patients treated with transarterial embolization for unresectable hepatocellular carcinoma.

Reichman TW, Bahramipour P, Barone A, Koneru B, Fisher A, Contractor D, Wilson D, Dela Torre A, Cho KC, Samanta A, Harrison LE.

J Gastrointest Surg. 2005 May-Jun;9(5):638-45.

PMID:
15862257
27.

Cytoreductive surgery and intraoperative hyperthermic chemoperfusion for advanced ovarian carcinoma.

Reichman TW, Cracchiolo B, Sama J, Bryan M, Harrison J, Pliner L, Harrison LE.

J Surg Oncol. 2005 May 1;90(2):51-6; discussion 56-8.

PMID:
15844187
29.

Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma.

Weitz J, Blumgart LH, Fong Y, Jarnagin WR, D'Angelica M, Harrison LE, DeMatteo RP.

Ann Surg. 2005 Feb;241(2):269-76.

30.
31.

Racial discrepancies in the outcome of patients with hepatocellular carcinoma.

Harrison LE, Reichman T, Koneru B, Fisher A, Wilson D, Dela Torre A, Samanta A, Korogodsky M.

Arch Surg. 2004 Sep;139(9):992-6.

PMID:
15381619
32.

Images in clinical medicine. Intussusception of the small bowel.

Harrison LE, Kim SH.

N Engl J Med. 2004 Jul 22;351(4):379. No abstract available.

33.

Phosphorylation of PPARgamma via active ERK1/2 leads to its physical association with p65 and inhibition of NF-kappabeta.

Chen F, Wang M, O'Connor JP, He M, Tripathi T, Harrison LE.

J Cell Biochem. 2003 Nov 1;90(4):732-44.

PMID:
14587029
34.

Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.

Harrison LE, Koneru B, Baramipour P, Fisher A, Barone A, Wilson D, Dela Torre A, Cho KC, Contractor D, Korogodsky M.

J Am Coll Surg. 2003 Nov;197(5):759-64.

PMID:
14585410
35.

Exposure to a deuterated analogue of phenylbutyrate retards S-phase progression in HT-29 colon cancer cells.

Clarke KO, Ludeman SM, Springer JB, Colvin OM, Lea MA, Harrison LE.

J Pharm Sci. 2002 Apr;91(4):1054-64.

PMID:
11948544
36.

Phenylbutyrate-induced apoptosis is associated with inactivation of NF-kappaB IN HT-29 colon cancer cells.

Feinman R, Clarke KO, Harrison LE.

Cancer Chemother Pharmacol. 2002 Jan;49(1):27-34.

PMID:
11855750
37.

Surgical implications of Helicobacter pylori infection.

Clarke KO, Harrison LE.

Front Biosci. 2001 Oct 1;6:E119-28. Review.

PMID:
11578955
38.

Tributyrin, an oral butyrate analogue, induces apoptosis through the activation of caspase-3.

Clarke KO, Feinman R, Harrison LE.

Cancer Lett. 2001 Sep 28;171(1):57-65.

PMID:
11485828
39.

Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors.

Wang D, de la Fuente C, Deng L, Wang L, Zilberman I, Eadie C, Healey M, Stein D, Denny T, Harrison LE, Meijer L, Kashanchi F.

J Virol. 2001 Aug;75(16):7266-79.

40.

Exploring the complex relationship between adolescent sexual offending and sex chromosome abnormality.

Harrison LE, Clayton-Smith J, Bailey S.

Psychiatr Genet. 2001 Mar;11(1):5-10.

PMID:
11409702
41.

Is esophageal cancer a surgical disease?

Harrison LE.

J Surg Oncol. 2000 Dec;75(4):227-31. No abstract available.

PMID:
11135262
42.

Changes in E2F binding after phenylbutyrate-induced differentiation of Caco-2 colon cancer cells.

Wang QM, Feinman R, Kashanchi F, Houghton JM, Studzinski GP, Harrison LE.

Clin Cancer Res. 2000 Jul;6(7):2951-8.

43.

Prognostic significance of immunohistochemical micrometastases in node negative gastric cancer patients.

Harrison LE, Choe JK, Goldstein M, Meridian A, Kim SH, Clarke K.

J Surg Oncol. 2000 Mar;73(3):153-7.

PMID:
10738269
44.

p53/56(lyn) antisense shifts the 1,25-dihydroxyvitamin D3-induced G1/S block in HL60 cells to S phase.

Wang QM, Studzinski GP, Chen F, Coffman FD, Harrison LE.

J Cell Physiol. 2000 May;183(2):238-46.

PMID:
10737899
45.

Butyrate-induced G2/M block in Caco-2 colon cancer cells is associated with decreased p34cdc2 activity.

Harrison LE, Wang QM, Studzinski GP.

Proc Soc Exp Biol Med. 1999 Nov;222(2):150-6.

PMID:
10564539
46.
47.

Commentary

Harrison LE.

J Surg Oncol. 1999 Sep;72(1):55-6. No abstract available.

PMID:
10477881
48.

Differentiation-related changes in the cell cycle traverse.

Studzinski GP, Harrison LE.

Int Rev Cytol. 1999;189:1-58. Review.

PMID:
10333577
49.

The impact of splenectomy on outcomes after resection of pancreatic adenocarcinoma.

Schwarz RE, Harrison LE, Conlon KC, Klimstra DS, Brennan MF.

J Am Coll Surg. 1999 May;188(5):516-21.

PMID:
10235580
50.

Intestinal permeability after early postoperative enteral nutrition in patients with upper gastrointestinal malignancy.

Brooks AD, Hochwald SN, Heslin MJ, Harrison LE, Burt M, Brennan MF.

JPEN J Parenter Enteral Nutr. 1999 Mar-Apr;23(2):75-9.

PMID:
10081996

Supplemental Content

Loading ...
Support Center